SNGX — Soligenix Inc.

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Soligenix Inc.

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma; SGX94… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$0.87
Market Cap$5.8M
Float14.0M
Shares Outstanding14.8M
P/E (Forward)12.32
Price/Sales (TTM)9.78
vs. Analyst Target+101.1% to analyst PT
Dividend RateNone
Analyst Target Price$1.75 (1 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $1.9M -$17.7M $109,584 -$18.5M
2021 $33,351 -$12.6M -$695,289 -$12.5M
2022 $250,000 -$13.8M -$300,822 -$14.1M
2023 $839,359 -$6.1M -$742,048 -$7.7M
2024 $119,371 -$8.3M -$119,371 -$9.5M
2025 N/A -$11.1M N/A -$11.8M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$2.7M
Sep 2025 N/A -$2.5M
Dec 2025 N/A -$2.9M
Mar 2026 N/A -$2.8M

Ownership & Float

Insider Ownership0.1%
Institutional Ownership5.3%
Short Float7.3%
% of All Funds Holding0.16%
Number of Funds Holding13

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$0.83Near-term / short-term trend
Weekly40-Week SMA$1.39Medium-term trend
Weekly80-Week SMA$1.85Cyclical trend (business cycle)
Weekly200-Week SMA$26.57Secular trend (multi-year)
Monthly10-Month SMA$1.36Near-term monthly trend
Monthly20-Month SMA$1.91Medium-term monthly trend
Monthly40-Month SMA$7.12Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$0.40 support 4.78x 0 months ago
$5.20 resistance 1.09x 22 months ago
$9.60 resistance 4.44x 24 months ago

Historical Earnings Reactions (106 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.77% 0.00% 27.36% 8.33% -10.71%
1 Day -0.60% 0.00% 31.13% 16.13% -25.00%
1 Week -0.22% -1.39% 37.74% 45.00% -25.00%
2 Weeks -1.60% -2.31% 34.91% 76.90% -48.72%
1 Month -2.99% -4.42% 40.00% 52.50% -78.57%

Next earnings: May 8, 2026

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan31.8%59.4%32
Feb1.7%43.8%32
Mar-4.8%31.3%32
Apr-14.4%15.6%32
May-6.5%34.4%32
Jun13.1%34.4%32
Jul8.9%50.0%32
Aug0.8%40.6%32
Sep-2.6%43.8%32
Oct-5.2%15.6%32
Nov3.7%37.5%32
Dec-1.9%40.6%32

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.01% 31.6% 1519
Tuesday 0.55% 31.8% 1662
Wednesday 0.82% 33.2% 1659
Thursday 0.91% 34.6% 1627
Friday 0.61% 36.2% 1622

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 5.3%

Insider Transactions — Smart Summary

Total insider ownership: 0.1%

Founder-led management: Christopher J. Schaber (Chairman, President and Chief Executive Officer)

12-Month Insider Activity Summary

Total Filings1
Net Value+$19,999.964
Net Shares Change15,132
% of Float0.1%
C-Suite Filings1
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
SCHABER CHRISTOPHER J CHAIRMAN, CEO AND PRESIDENT +$19,999.964 1 1 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-10-03 SCHABER CHRISTOPHER J CHAIRMAN, CEO AND PRESIDENT +$19,999.964 Transaction at $1.32, now -34.2%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Soligenix Inc. (SNGX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for SNGX on Trend Edge →